Lomustine
Overview
Lomustine is an alkylating nitrosourea compound that has been used in chemotherapy. It is used primarily for the treatment of brain tumors and Hodgkin's disease.
API suppliers (1)
Suppliers of Lomustine evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
- DR REDDYS LABORATORIES LTD1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (6 approved US products), the latest listed US patent on Lomustine expires — and exclusivity 19 May 2026. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Lomustine? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.